The irony of chirality - unveiling the distinct mechanistic binding and activities of 1-(3-(4-amino-5-(7-methoxy-5-methylbenzo[b]thiophen-2-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)pyrrolidin-1-yl)prop-2-en-1-one enantiomers as irreversible covalent FGFR4 inhibitors

被引:26
作者
Akher, Farideh Badichi [1 ]
Farrokhzadeh, Abdolkarim [1 ]
Olotu, Fisayo A. [1 ]
Agoni, Clement [1 ]
Soliman, Mahmoud E. S. [1 ]
机构
[1] Univ KwaZulu Natal, Sch Hlth Sci, Mol Biocomputat & Drug Design Lab, Westville Campus, ZA-4001 Durban, South Africa
关键词
SELECTIVE INHIBITOR; OVERCOME RESISTANCE; DISCOVERY; COMPLEX; POTENT; DERIVATIVES; DESIGN;
D O I
10.1039/c8ob02811g
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
The influence of chirality on the therapeutic activities of drug molecules has remained an interesting subject matter in drug design. The recent identification of two chiral irreversible inhibitors with differential inhibitory activities towards oncogenic fibroblast growth factor receptor 4 (FGFR4) presented an avenue to investigate the underlying mechanisms that accounted for their disparate activities. Accordingly, the S-configured form (9g) exhibited '15 times' potency than the corresponding R-configured (9h) form. Nonetheless, the big question remains how does chirality influence their inhibitory potencies? Therefore, in this study, we seek to provide useful insights into this interesting phenomenon using molecular dynamics simulations and free binding energy calculations. Interestingly, we observed that the inhibitory 9g activity correlates with a coordinated movement of the active site p-loop, as specifically induced by the S-configuration, which allowed the rotation of three dihedral angles; phi(1(CNCO)), phi(2(CCC*N)) and phi(3(CCCC)), thereby achieving optimal orientations suitable for interactions with crucial active site residues such as LEU473, LYS503, ASP641 and TYR643. Consequentially, while the 9h-bound FGFR4 active site was highly unstable, 9g exerted an inward pulling effect which accounted for active site stability and compactness. Also, the positional movement of 9h (R-configuration) at the active site was restricted, thereby preventing interactions with key residues. Moreover, 9g exhibited the most favorable binding as compared to 9h which showed a relatively lower Delta G(bind). The higher binding affinity of 9g to FGFR4 can be mainly attributed to the increase in van der Waals energy by -4.12 kcal mol(-1) and electrostatic by -2.89 kcal mol(-1). The difference in van der Waals interactions is mainly determined by two residues; ASP641 and TYR643, whilst, the difference in electrostatic interactions is primarily determined by two residues LEU473 and LYS503.
引用
收藏
页码:1176 / 1190
页数:15
相关论文
共 49 条
[1]   DENSITY-FUNCTIONAL THERMOCHEMISTRY .3. THE ROLE OF EXACT EXCHANGE [J].
BECKE, AD .
JOURNAL OF CHEMICAL PHYSICS, 1993, 98 (07) :5648-5652
[2]   E-3810 Is a Potent Dual Inhibitor of VEGFR and FGFR that Exerts Antitumor Activity in Multiple Preclinical Models [J].
Bello, Ezia ;
Colella, Gennaro ;
Scarlato, Valentina ;
Oliva, Paolo ;
Berndt, Alexander ;
Valbusa, Giovanni ;
Serra, Sonia Colombo ;
D'Incalci, Maurizio ;
Cavalletti, Ennio ;
Giavazzi, Raffaella ;
Damia, Giovanna ;
Camboni, Gabriella .
CANCER RESEARCH, 2011, 71 (04) :1396-1405
[3]   Discovery of the Irreversible Covalent FGFR Inhibitor 8-(3-(4-Acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (PRN1371) for the Treatment of Solid Tumors [J].
Brameld, Ken A. ;
Owens, Timothy D. ;
Verner, Erik ;
Venetsanakos, Eleni ;
Bradshaw, J. Michael ;
Phan, Vernon T. ;
Tam, Danny ;
Leung, Kwan ;
Shu, Jin ;
LaStant, Jacob ;
Loughhead, David G. ;
Ton, Tony ;
Karr, Dane E. ;
Gerritsen, Mary E. ;
Goldstein, David M. ;
Funk, Jens Oliver .
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (15) :6516-6527
[4]   Covalent Targeting of Fibroblast Growth Factor Receptor Inhibits Metastatic Breast Cancer [J].
Brown, Wells S. ;
Tan, Li ;
Smith, Andrew ;
Gray, Nathanael S. ;
Wendt, Michael K. .
MOLECULAR CANCER THERAPEUTICS, 2016, 15 (09) :2096-2106
[5]   Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction [J].
Carter, Edward P. ;
Fearon, Abbie E. ;
Grose, Richard P. .
TRENDS IN CELL BIOLOGY, 2015, 25 (04) :221-233
[6]  
Case D. A., 2014, AMBER 14, P826
[7]   An overview of the binding models of FGFR tyrosine kinases in complex with small molecule inhibitors [J].
Cheng, Weiyan ;
Wang, Mixiang ;
Tian, Xin ;
Zhang, Xiaojian .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 126 :476-490
[8]   Fibroblast Growth Factor Receptor Inhibitors as a Cancer Treatment: From a Biologic Rationale to Medical Perspectives [J].
Dieci, Maria Vittoria ;
Arnedos, Monica ;
Andre, Fabrice ;
Soria, Jean Charles .
CANCER DISCOVERY, 2013, 3 (03) :264-279
[9]  
Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/0471250953.bi0506s47, 10.1002/cpbi.3, 10.1002/cpps.20]
[10]   Overexpression of uridine phosphorylase 2 (UPP2) in tissues of uridine phosphorylase (UPP1) knock-out mice [J].
Gao, Yang ;
Ziemba, Amy ;
Turner, Jennifer ;
Pizzorno, Giuseppe .
CANCER RESEARCH, 2010, 70